Doctor-led weight loss using GLP-1 medication, AI coaching, and a personalised plan — all delivered to your door. No crash diets. No guesswork.
More predictive than BMI alone for Indian metabolic risk
ⓘ High risk: above 90 cm (men) / 80 cm (women)
You may qualify for GLP-1. Take the 2-min quiz to confirm.
No commitment · Free doctor call · Cancel anytime
Not crash diets. Not willpower. Biology working in your favour.
"I've had PCOS since I was 19 and every doctor just told me to 'eat less and exercise more.' ALTRcare actually ran bloodwork first, found my insulin resistance, and built a plan around it. I lost 11 kg in 4 months — but more importantly my cycles are regular for the first time in seven years."
"Maine kai baar try kiya — gym, keto, intermittent fasting. Sab kuch chhod diya kyunki results nahi the. ALTRcare ke doctor ne pehli baar explain kiya ke mera body actually hunger hormones ke against fight kar raha tha. 6 mahine mein 19 kg gaye. Ab main maintain kar raha hoon."
"I travel 3 weeks out of every month for work. The WhatsApp coaching was the only thing that actually fit my life — my coach would adjust my meal plan based on which city I was in. The doctor call took 20 minutes. Medication arrived in 2 days. Down 14 kg and my sleep has completely changed."
"My endocrinologist had mentioned semaglutide but said the waiting time at his clinic was 3 months. ALTRcare had me on a call within 48 hours. The bloodwork was done at home, results came in 4 days, and I was on my first dose within a week. 8 kg down in 10 weeks."
"I was sceptical — I thought this would be another 'wellness subscription' that sends you a PDF and disappears. My nutritionist calls me every week without fail. When I had nausea in week 3, my doctor adjusted my dose the same day I messaged. That kind of support is what made the difference."
"My husband and I both joined — we figured we'd keep each other accountable. He lost 21 kg, I lost 13 kg. Different doctors, different doses, completely different plans even though we eat the same food at home. That's what surprised me most — it was actually personalised, not a template."
No clinic visits. No crash dieting. Start online in minutes.
Answer 6 quick questions about your health, goals, and history. Takes 2 minutes.
Meet a board-certified physician via video. They'll review your full health history — at no cost.
Your doctor determines whether GLP-1 or an alternative is clinically right for you. No one-size-fits-all prescriptions.
Your prescription is sent digitally. Medication is dispatched via licensed pharmacy and arrives in 2–4 days.
Weekly doctor check-ins, 24/7 coaching on WhatsApp, and continuous dose optimisation.
Answer 6 quick questions about your health. Takes 2 minutes.
Meet a board-certified physician via video — at no cost.
Your doctor decides if GLP-1 is clinically right for you. No algorithm.
Medication dispatched via licensed pharmacy. Arrives in 2–4 days.
Weekly check-ins, 24/7 WhatsApp coaching, dose optimisation.
Answer 6 quick questions. We'll show you exactly what to expect — no commitment needed.
Move the sliders to your measurements. We use this to estimate your results.
You choose which medication fits your goal and budget. Your doctor reviews your bloodwork, confirms eligibility, and manages your dose — every month.
The proven protocol — semaglutide
3-month commitment recommended · cancel anytime
~15% average body weight reduction
Free doctor call first · Prescribed only if appropriate
For faster, deeper results — tirzepatide
3-month commitment recommended · cancel anytime
~20–22% average body weight reduction
Free doctor call first · Prescribed only if appropriate
Not sure which is right for you?
Bloodwork included
Baseline blood panel worth ₹800–1,000 — done at home, no clinic visit
MCI-registered doctors
Board-certified physicians review every case before prescribing
No lock-in
Cancel or pause from WhatsApp — no forms, no phone calls
The science behind GLP-1
Phase III Indian trial confirms semaglutide is effective and safe in Indian adults with obesity — the "Asian Indian phenotype" responds well at lower BMI thresholds.
Tirzepatide achieved up to 22.5% weight reduction — the largest seen in any obesity pharmacotherapy trial to date.
254 million Indian adults have generalised obesity. Indians carry more visceral fat at lower BMIs — metabolic risk starts earlier than Western guidelines suggest.
Research Society for Study of Diabetes in India recommends GLP-1 receptor agonists as preferred therapy for Indian patients with obesity-related cardiovascular risk.
Individual results vary. GLP-1 medications are prescribed only when clinically appropriate based on your health profile and bloodwork.
Every ALTRcare plan is backed by straightforward promises — not fine print.
Not happy in your first 30 days with the service? Contact your care team and we'll make it right — adjusting your plan, changing your support team, or issuing a refund for unused months. No awkward conversations.
Cancel or pause your plan anytime via WhatsApp — no forms, no phone calls, no waiting on hold. We keep you because the programme works, not because you're locked in.
The 30-day satisfaction promise covers service quality — not clinical outcomes, which depend on individual health profile and adherence. GLP-1 medications are prescribed only when clinically appropriate.
Share your personalised referral link with a friend. When they join any ALTRcare plan, you both get ₹1,000 off your next month — automatically applied by your care team.
No limit on referrals. Stack discounts month after month.
Tap the button below to send your unique referral message to a friend.
They mention your name when they sign up. Our team verifies it.
Discount applied to your next month and their first month.
Discount verified manually by your care team within 24 hours of your friend's sign-up.
Everything you need to know before you start.
Evidence-based articles for patients, doctors, and the curious.
Both drugs work. But tirzepatide averages 20–22% weight loss vs 15% for semaglutide — and costs significantly more. Here's how doctors in India decide which to prescribe.
Ozempic, Wegovy, Mounjaro — what's available in India, what's CDSCO-approved, what each costs, and how to get prescribed without a 3-month clinic wait.
Indian bodies store more visceral fat at lower BMIs. A waist above 90 cm (men) or 80 cm (women) is a stronger trigger for GLP-1 prescribing than BMI alone.
Insulin resistance drives PCOS weight gain — and GLP-1 medications directly target insulin signalling. Here's the clinical evidence and what to expect.
Are they safe? Are they steroids? Do you regain weight? 12 of the most common questions Indian patients ask — answered plainly by our medical team.
136 million Indians have pre-diabetes. Most don't know. GLP-1 therapy combined with lifestyle changes has been shown to reverse pre-diabetes in 60–80% of patients.
Start your weight loss journey with expert doctors, personalized coaching, and proven results.